Loading clinical trials...
Loading clinical trials...
Cord Blood Transplantation for Hematologic Malignancies and Bone Marrow Failure Syndromes
Conditions
Interventions
anti-thymocyte globulin
filgrastim
+7 more
Locations
1
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
September 4, 1997
Primary Completion Date
October 16, 2017
Completion Date
October 16, 2017
Last Updated
December 13, 2019
NCT05139017
NCT07388563
NCT06337318
NCT06263491
NCT05529069
NCT06285890
Lead Sponsor
Roswell Park Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions